A research team from Italy reported that a glance of light might provide relief from pain. They first identified the oversensitive nerve cells that cause chronic pain. Then, a light-sensitive chemical was developed and injected, which binds to these nerve cells. Next, a flash of near-infrared light was passed to the exact nerve in order to provide instant pain relief. This strategy was experimentally proved in mice.
Kineta Chronic Pain, LLC, a subsidiary of Kineta, Inc., today announced that it has entered into an exclusive option and license agreement with Genentech, a member of the Roche Group, to develop Kineta’s α9/α10 nicotinic acetylcholine receptor (nAChR) antagonists for the treatment of chronic pain.
your submission has already been received.
Please enter a valid Email address！
The most relevant industry news & insight will be sent to you every two weeks.